Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Video

» Interview

Treatment of AS in Young Patients

June 24, 2024

Video

» Interview

Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

September 18, 2022

Video

» Interview

Updated Cumulative Results of Treatment with Mavacamten from the EXPLORER-LTE Cohort of the MAVA-LTE Study in Patients with Obstructive Hypertrophic Cardiomyopathy

May 4, 2022

Video

» Interview

ACC 2022: One-year Results of the Clasp TR Study: Transcatheter Treatment of Tricuspid Regurgitation

April 3, 2022

Video

» Interview

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

November 7, 2021

Video

» Interview

PROSPECT ABSORB: A Randomized Trial of Interventional Treatment of Vulnerable Plaques

October 14, 2020

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Maurizio Taramasso About a Propensity Score-Matched Analysis of Transcatheter Tricuspid Valve Treatment vs. Medical Treatment in Patients With Severe Tricuspid Regurgitation

September 27, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Dean Kereiakis About the First Human Use of a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor (RUC-4) Designed for STEMI Point of Care Treatment

September 26, 2019

Advertisement

Treatment of AS in Young Patients

Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Updated Cumulative Results of Treatment with Mavacamten from the EXPLORER-LTE Cohort of the MAVA-LTE Study in Patients with Obstructive Hypertrophic Cardiomyopathy

ACC 2022: One-year Results of the Clasp TR Study: Transcatheter Treatment of Tricuspid Regurgitation

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

PROSPECT ABSORB: A Randomized Trial of Interventional Treatment of Vulnerable Plaques

Dr. C. Michael Gibson Talks With Dr. Maurizio Taramasso About a Propensity Score-Matched Analysis of Transcatheter Tricuspid Valve Treatment vs. Medical Treatment in Patients With Severe Tricuspid Regurgitation

Dr. C. Michael Gibson Talks With Dr. Dean Kereiakis About the First Human Use of a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor (RUC-4) Designed for STEMI Point of Care Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content